Lisa C Silbert1, Diane B Howieson, Hiroko Dodge, Jeffrey A Kaye. 1. Layton Aging and Alzheimer's Disease Center, Department of Neurology, CR-131, Oregon Health & Science University, 3181 S.W. Sam Jackson Park Rd., Portland, OR 97239, USA. silbertl@ohsu.edu
Abstract
OBJECTIVE: To determine whether white matter hyperintensity (WMH) progression rate is a better predictor of cognitive impairment risk than baseline WMH volume in healthy elderly individuals. METHOD: Ninety-eight cognitively intact elderly subjects were followed in the Oregon Brain Aging Study. Forty-nine had at least 3 brain MRIs and annual cognitive and neurologic assessments until diagnosed with persistent cognitive impairment (PCI). Brain, ventricular CSF (vCSF), intracranial volume (ICV), hippocampus, total WMH, periventricular (PV) WMH, and subcortical WMH volumes were measured. Cox proportional hazards survival analyses were used to assess cognitive impairment risk. RESULTS: After adjusting for age, apolipoprotein E4 status, incident hypertension, ICV, entry Mini-Mental State Examination, baseline hippocampus, and both baseline vCSF volume and rate of vCSF volume change, increased progression of total WMH volume (hazard ratio [HR] 1.84, 95% confidence interval [CI] 1.3-2.7, p = 0.0007) and PV WMH volume (HR 1.94, 95% CI 1.3-3.1, p = 0.001) conferred higher risk of PCI, whereas baseline WMH volumes did not. Every 1 mL/y increase in PV WMH volume was associated with a 94% increased risk of PCI. CONCLUSION: Progression of total and periventricular (PV) white matter hyperintensity (WMH) volumes are better predictors of persistent cognitive impairment (PCI) than baseline WMH burden. Greater PV WMH burden progression is associated with the development of PCI, a potential precursor to Alzheimer or vascular dementia. Identification of factors that decrease WMH accumulation over time is needed to maintain cognitive health in our growing elderly population.
OBJECTIVE: To determine whether white matter hyperintensity (WMH) progression rate is a better predictor of cognitive impairment risk than baseline WMH volume in healthy elderly individuals. METHOD: Ninety-eight cognitively intact elderly subjects were followed in the Oregon Brain Aging Study. Forty-nine had at least 3 brain MRIs and annual cognitive and neurologic assessments until diagnosed with persistent cognitive impairment (PCI). Brain, ventricular CSF (vCSF), intracranial volume (ICV), hippocampus, total WMH, periventricular (PV) WMH, and subcortical WMH volumes were measured. Cox proportional hazards survival analyses were used to assess cognitive impairment risk. RESULTS: After adjusting for age, apolipoprotein E4 status, incident hypertension, ICV, entry Mini-Mental State Examination, baseline hippocampus, and both baseline vCSF volume and rate of vCSF volume change, increased progression of total WMH volume (hazard ratio [HR] 1.84, 95% confidence interval [CI] 1.3-2.7, p = 0.0007) and PV WMH volume (HR 1.94, 95% CI 1.3-3.1, p = 0.001) conferred higher risk of PCI, whereas baseline WMH volumes did not. Every 1 mL/y increase in PV WMH volume was associated with a 94% increased risk of PCI. CONCLUSION: Progression of total and periventricular (PV) white matter hyperintensity (WMH) volumes are better predictors of persistent cognitive impairment (PCI) than baseline WMH burden. Greater PV WMH burden progression is associated with the development of PCI, a potential precursor to Alzheimer or vascular dementia. Identification of factors that decrease WMH accumulation over time is needed to maintain cognitive health in our growing elderly population.
Authors: Lon White; Helen Petrovitch; John Hardman; James Nelson; Daron G Davis; G Webster Ross; Kamal Masaki; Lenore Launer; William R Markesbery Journal: Ann N Y Acad Sci Date: 2002-11 Impact factor: 5.691
Authors: Scott Marquis; M Milar Moore; Diane B Howieson; Gary Sexton; Haydeh Payami; Jeffrey A Kaye; Richard Camicioli Journal: Arch Neurol Date: 2002-04
Authors: S Adak; K Illouz; W Gorman; R Tandon; E A Zimmerman; R Guariglia; M M Moore; J A Kaye Journal: Neurology Date: 2004-07-13 Impact factor: 9.910
Authors: Hazel Mae A Abraham; Leslie Wolfson; Nicola Moscufo; Charles R G Guttmann; Richard F Kaplan; William B White Journal: J Cereb Blood Flow Metab Date: 2016-01 Impact factor: 6.200
Authors: Melinda C Power; Jennifer A Deal; A Richey Sharrett; Clifford R Jack; David Knopman; Thomas H Mosley; Rebecca F Gottesman Journal: Neurology Date: 2015-01-28 Impact factor: 9.910
Authors: Melissa E Murray; Prashanthi Vemuri; Greg M Preboske; Matthew C Murphy; Katherine J Schweitzer; Joseph E Parisi; Clifford R Jack; Dennis W Dickson Journal: J Neuropathol Exp Neurol Date: 2012-12 Impact factor: 3.685
Authors: Hiroko H Dodge; Jian Zhu; Danielle Harvey; Naomi Saito; Lisa C Silbert; Jeffrey A Kaye; Robert A Koeppe; Roger L Albin Journal: Alzheimers Dement Date: 2014-07-09 Impact factor: 21.566
Authors: Erin D Michos; Kathryn A Carson; Andrea L C Schneider; Pamela L Lutsey; Li Xing; A Richey Sharrett; Alvaro Alonso; Laura H Coker; Myron Gross; Wendy Post; Thomas H Mosley; Rebecca F Gottesman Journal: JAMA Neurol Date: 2014-07-01 Impact factor: 18.302
Authors: Lisa C Silbert; Hiroko H Dodge; Louie G Perkins; Lena Sherbakov; David Lahna; Deniz Erten-Lyons; Randall Woltjer; Lynne Shinto; Jeffrey A Kaye Journal: Neurology Date: 2012-07-25 Impact factor: 9.910
Authors: Thomas C Hanff; A Richey Sharrett; Thomas H Mosley; Dean Shibata; David S Knopman; Ronald Klein; Barbara E K Klein; Rebecca F Gottesman Journal: Stroke Date: 2014-02-18 Impact factor: 7.914
Authors: Rebecca F Gottesman; Josef Coresh; Diane J Catellier; A Richey Sharrett; Kathryn M Rose; Laura H Coker; Dean K Shibata; David S Knopman; Clifford R Jack; Thomas H Mosley Journal: Stroke Date: 2009-11-19 Impact factor: 7.914